Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential.
Nao SuzukiYasushi TakaiMasahito YonemuraHiromitsu NegoroShinya MotonagaNoriko FujishiroEishin NakamuraSeido TakaeSaori YoshidaKoji UesugiTakashi OhiraAiko KatsuraMichio FujiwaraItsuko HoriguchiKenjiro KosakiHiroshi OnoderaHiroyuki NishiyamaPublished in: International journal of clinical oncology (2022)
The "Guidance on the Need for Contraception Related to Use of Pharmaceuticals" (The report of the Study Group for Providing Information on the Proper Use of Pharmaceuticals in Patients with Reproductive Potential, Research on Regulatory Science of Pharmaceuticals and Medical Devices, Japan Agency for Medical Research and Development: JP20mk0101139) is expected to help Japanese healthcare professionals provide fertility-related care and advice to adolescents, and young adults with cancer and their families.